KZR logo

Kezar Life Sciences (KZR) Company Overview

Profile

Full Name:

Kezar Life Sciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 21, 2018

Indexes:

Not included

Website:

http://www.kezarlifesciences.com

Description:

Kezar Life Sciences is a biotechnology company focused on developing innovative treatments for autoimmune diseases and cancer. They use advanced science to create new therapies that target specific pathways in the body, aiming to improve patient outcomes and quality of life.

Key Details

Price

$5.98

Market Cap

$43.63 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$7.00 M

Annual EPS

-$14.00(-38.61% YoY)

PE Ratio

-

Annual ROE

-44.54%

Annual Debt To Equity

0.05

Beta

0.87

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 30, 2024

Analyst ratings

Recent major analysts updates

Dec 19, 24 Wells Fargo
Equal-Weight
Dec 2, 24 HC Wainwright & Co.
Neutral
Nov 14, 24 Wells Fargo
Equal-Weight
Oct 18, 24 HC Wainwright & Co.
Neutral
Oct 14, 24 HC Wainwright & Co.
Neutral
Oct 2, 24 HC Wainwright & Co.
Neutral
Aug 14, 24 HC Wainwright & Co.
Buy
Jul 22, 24 HC Wainwright & Co.
Buy
May 10, 24 HC Wainwright & Co.
Buy
Mar 15, 24 HC Wainwright & Co.
Buy

Screeners with KZR included

Growing Shares Outstanding
US stocks
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Earnings next week

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$5.98
KZR price is $5.98

Price All-time High

$329.00
KZR price is currently -98.18% below its historical high of $329.00

Price Analysts Target

$13.50
KZR price is currently -55.70% lower than the consensus analysts' forecast

Price Today Change

+4.73%
KZR price is up +4.73% today

Price YTD Change

-11.01%
KZR price is down -11.01% since January 1st

Price 3-Year Change

-95.67%
KZR price is down -95.67% over the past 3 years

Market cap

Market Cap

$43.63 M
KZR market capitalization is $43.63 million

Market Cap 3-Year Change

-94.38%
KZR market capitalization is down -94.38% over the past 3 years

Market Cap All-time High

$1.04 B
KZR market capitalization is currently -95.80% below its historical high of $1.04 billion

Market Cap Sector Rank

34.62%
KZR market capitalization is higher than 34.62% of companies in Healthcare sector

Technical

Beta

0.87
KZR beta is 0.87

200-day SMA

$6.68
KZR price is currently -10.54% below its 200-day simple moving average

14-day RSI

36.22
KZR 14-day relative strength index is 36.22

30-day Relative Volume

1.02
KZR 30-day relative volume is 1.02

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$7.00 M
KZR annual revenue is $7.00 million

Annual Revenue Analysts Estimate

-
KZR annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
KZR annual revenue 1-year change is unknown

Annual Revenue Sector Rank

25.9%
KZR annual revenue is higher than 25.9% of companies in Healthcare sector

Profit

Annual Gross Profit

-
KZR annual gross profit value is unknown

Annual Gross Margin

-
KZR annual gross profit margin value is unknown

Annual Operating Profit

-$105.24 M
KZR annual operating income is -$105.24 million

Annual Operating Margin

-1503.39%
KZR annual operating profit margin is -1503.39%

Annual Net Income

-$101.87 M
KZR annual net profit is -$101.87 million

Annual Net Margin

-1455.29%
KZR annual net profit margin is -1455.29%

EPS

Annual EPS

-$14.00
KZR annual earnings per share is -$14.00

Annual EPS Analysts Estimate

-$6.70
KZR annual earnings per share is currently +108.96% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-38.61%
KZR annual earnings per share is down -38.61% year-on-year

Annual EPS Sector Rank

12.58%
KZR annual earnings per share is higher than 12.58% of companies in Healthcare sector

ROA & ROE

Annual ROA

-46.05%
KZR annual return on assets is -46.05%

Annual ROE

-44.54%
KZR annual return on equity is -44.54%

EBIT & EBITDA

Annual EBIT

-$100.32 M
KZR annual earnings before interest & taxes is -$100.32 million

Annual EBITDA

-$99.25 M
KZR annual EBITDA is -$99.25 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
KZR price to earnings ratio value is unknown

PE Ratio Sector Rank

-
KZR price to earnings ratio is unknown

PB Ratio

PB Ratio

0.33
KZR price to book ratio is 0.33

PB Ratio Sector Rank

22.75%
KZR price to book ratio is higher than 22.75% of companies in Healthcare sector

PS Ratio

PS Ratio

-
KZR price to sales ratio value is unknown

PS Ratio Sector Rank

-
KZR price to sales ratio is unknown

Enterprise value

Enterprise Value

$25.69 M
KZR enterprise value is $25.69 million

Enterprise Value Sector Rank

32.64%
KZR enterprise value is higher than 32.64% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.28
KZR EV/EBITDA is -0.28

EV/EBITDA Sector Rank

58.54%
KZR EV/EBITDA is higher than 58.54% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

11.66
KZR annual current ratio is 11.66

Annual Quick Ratio

-
KZR annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.05
KZR annual debt to equity ratio is 0.05

Annual Interest Coverage Ratio

-64.72
KZR annual interest coverage ratio is -64.72

Risk & Stability

Piotroski F-Score

-
KZR piotroski f-score value is unknown

Altman Z-Score

-1.88
KZR altman z-score is -1.88

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$221.24 M
KZR annual total assets is $221.24 million

Annual Non Current Assets

$14.29 M
KZR annual long term assets is $14.29 million

Annual Current Assets

$206.95 M
KZR annual total current assets is $206.95 million

Annual Cash & Cash Equivalents

$35.49 M
KZR annual cash & cash equivalents is $35.49 million

Equity

Annual Book Value

$187.57 M
KZR annual book value is $187.57 million

Annual Working Capital

$189.21 M
KZR annual working capital is $189.21 million

Liabilities

Annual Total Liabilities

$33.66 M
KZR annual total liabilities is $33.66 million

Annual Total Long Term Liabilities

$15.92 M
KZR annual total long term liabilities is $15.92 million

Annual Current Liabilities

$17.74 M
KZR annual total current liabilities is $17.74 million

Annual Accounts Payable

$8.25 M
KZR annual accounts payable is $8.25 million

Debt

Annual Total Debt

$18.93 M
KZR annual total debt is $18.93 million

Annual Total Debt 1-Year Change

-10.96%
KZR annual total debt is down -10.96% year-on-year

Annual Long Term Debt

$15.92 M
KZR annual long term debt is $15.92 million

Annual Short Term Debt

$3.01 M
KZR annual short term debt is $3.01 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$112.24 M
KZR annual total expenses is $112.24 million

Annual Operating Expenses

$112.24 M
KZR annual total operating expenses is $112.24 million

Annual Cost Of Goods Sold

-
KZR annual cost of goods sold value is unknown

Annual SGA

$26.54 M
KZR annual SGA is $26.54 million

Annual D&A

$1.07 M
KZR annual depreciation & amortization is $1.07 million

Annual Interest Expense

$1.55 M
KZR annual interest expense is $1.55 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$81.64 M
KZR annual cash flow from operations is -$81.64 million

Annual CFO 1-Year Change

-38.74%
KZR annual cash flow from operations is down -38.74% year-on-year

Annual CFI

$76.05 M
KZR annual cash flow from investing activities is $76.05 million

Annual CFI 1-Year Change

+183.21%
KZR annual cash flow from investing activities is up +183.21% year-on-year

Annual CFF

$638.00 K
KZR annual cash flow from financing activities is $638.00 thousand

Annual CFF 1-Year Change

-99.5%
KZR annual cash flow from financing activities is down -99.5% year-on-year

Free CashFlow

Annual FCF

-$83.45 M
KZR annual free cash flow is -$83.45 million

Annual FCF 1-Year Change

-38.12%
KZR annual free cash flow is down -38.12% year-on-year

CAPEX

Annual CAPEX

$1.81 M
KZR annual capital expenditures is $1.81 million

Annual CAPEX 1-Year Change

-
KZR annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

BRNS logo
Barinthus Biotherapeutics (BRNS)
ATHE logo
Alterity Therapeutics Limited (ATHE)
PRLD logo
Prelude Therapeutics Incorporated (PRLD)
FGEN logo
FibroGen (FGEN)
SHLT logo
SHL Telemedicine (SHLT)
DTIL logo
Precision BioSciences (DTIL)
OKYO logo
OKYO Pharma Limited (OKYO)
SCLX logo
Scilex Holding (SCLX)
LTRN logo
Lantern Pharma (LTRN)

FAQ

  • What is the ticker symbol for Kezar Life Sciences?
  • Does Kezar Life Sciences pay dividends?
  • What sector is Kezar Life Sciences in?
  • What industry is Kezar Life Sciences in?
  • What country is Kezar Life Sciences based in?
  • When did Kezar Life Sciences go public?
  • Is Kezar Life Sciences in the S&P 500?
  • Is Kezar Life Sciences in the NASDAQ 100?
  • Is Kezar Life Sciences in the Dow Jones?
  • When was Kezar Life Sciences's last earnings report?
  • When does Kezar Life Sciences report earnings?
  • Should I buy Kezar Life Sciences stock now?

What is the ticker symbol for Kezar Life Sciences?

The ticker symbol for Kezar Life Sciences is NASDAQ:KZR

Does Kezar Life Sciences pay dividends?

No, Kezar Life Sciences does not pay dividends

What sector is Kezar Life Sciences in?

Kezar Life Sciences is in the Healthcare sector

What industry is Kezar Life Sciences in?

Kezar Life Sciences is in the Biotechnology industry

What country is Kezar Life Sciences based in?

Kezar Life Sciences is headquartered in United States

When did Kezar Life Sciences go public?

Kezar Life Sciences's initial public offering (IPO) was on June 21, 2018

Is Kezar Life Sciences in the S&P 500?

No, Kezar Life Sciences is not included in the S&P 500 index

Is Kezar Life Sciences in the NASDAQ 100?

No, Kezar Life Sciences is not included in the NASDAQ 100 index

Is Kezar Life Sciences in the Dow Jones?

No, Kezar Life Sciences is not included in the Dow Jones index

When was Kezar Life Sciences's last earnings report?

Kezar Life Sciences's most recent earnings report was on Nov 12, 2024

When does Kezar Life Sciences report earnings?

The next expected earnings date for Kezar Life Sciences is Mar 14, 2025

Should I buy Kezar Life Sciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions